Novavax
NVAX
NVAX
235 hedge funds and large institutions have $1.19B invested in Novavax in 2024 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 66 increasing their positions, 64 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.9% less ownership
Funds ownership: 59.47% → 58.57% (-0.9%)
25% less call options, than puts
Call options by funds: $124M | Put options by funds: $164M
Holders
235
Holding in Top 10
2
Calls
$124M
Puts
$164M
Top Buyers
| 1 | +$20.9M | |
| 2 | +$19.9M | |
| 3 | +$17.5M | |
| 4 |
SG Americas Securities
New York
|
+$13.5M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$12.9M |
Top Sellers
| 1 | -$22.4M | |
| 2 | -$6.73M | |
| 3 | -$5.17M | |
| 4 |
D.E. Shaw & Co
New York
|
-$4.97M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$4.66M |